A recent FDA clarification makes it clear that product needs to be treated as a Medicine. I believe that this will make it likely that clinics will have to close doors or face possible Malpractice suits.
This news, and the news sent out yesterday to current stockholders (of the impending dilution of 250,000,000,000 new shares - 20 days after Friday's letter) may result in a stock sell off early next week.
Of course, I have learned all I know in the last two weeks. I could be way wrong.